[Chronic granulomatous disease].
Iwata
M
M
Ashikita Institution for Developmental Disabilities.
Nunoi
H
H
D000890:Anti-Infective Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D003937:Diagnosis, Differential; D005808:Genes, Recessive; D015316:Genetic Therapy; D006105:Granulomatous Disease, Chronic / Q000145:classification / Q000209:etiology; D006801:Humans; D008562:Membrane Glycoproteins / Q000172:deficiency / Q000235:genetics; D026901:Membrane Transport Proteins; D009154:Mutation; D009252:NADPH Dehydrogenase / Q000172:deficiency / Q000235:genetics; D000074662:NADPH Oxidase 2; D019255:NADPH Oxidases; D010750:Phosphoproteins / Q000172:deficiency / Q000235:genetics; D011379:Prognosis
D000890:Anti-Infective Agents; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D010750:Phosphoproteins; C079789:neutrophil cytosol factor 67K; C056558:CYBB protein, human; D000074662:NADPH Oxidase 2; D019255:NADPH Oxidases; C086986:CYBA protein, human; C060505:neutrophil cytosolic factor 1; D009252:NADPH Dehydrogenase